Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Hantech Bio-Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	216.25	382.42	167.09	75.04	86.41	81.78
Cash & Short-Term Investments	306.97	382.42	167.09	75.04	86.41	81.78
Cash Growth	-25.61%	128.87%	122.67%	-13.16%	5.66%	305.45%
Accounts Receivable	115.21	80.56	88.43	50.06	24.94	31.23
Other Receivables	0.65	0.21	0.21	0.01	0.01	6.45
Receivables	115.87	80.76	88.64	50.07	24.95	37.68
Inventory	87.49	70.34	80.47	29.32	22.04	19.79
Prepaid Expenses	1.22	1.11	3.72	4.24	1.78	2.18
Other Current Assets	0.02	-	-	-	-	0.23
Total Current Assets	511.57	534.63	339.91	158.68	135.17	141.66
Property, Plant & Equipment	564.59	566.87	551.32	285.23	227.04	164.34
Other Intangible Assets	4.68	5.96	3.25	1.47	1.2	0.6
Long-Term Deferred Tax Assets	2.64	1.79	1.81	2.27	1.06	0.32
Other Long-Term Assets	7.14	9.75	34.65	25.95	11.17	3.35
Total Assets	1,091	1,119	930.94	473.59	375.65	310.27
Accounts Payable	81.43	46.33	99.17	33.7	13.67	16.41
Accrued Expenses	53.97	43.56	49.75	25.29	25.4	24.43
Short-Term Debt	5	-	-	1	4	-
Current Portion of Long-Term Debt	33.37	51.22	23.18	5.94	5.06	2.58
Current Portion of Leases	6.29	6.26	6.63	6.57	6.78	5.25
Current Income Taxes Payable	7.24	21.73	30.01	8.91	0.97	14.04
Current Unearned Revenue	13.27	13.25	10.38	13.51	10.24	15.17
Other Current Liabilities	2.81	9.86	5.22	1.82	1.21	1.66
Total Current Liabilities	203.38	192.21	224.34	96.74	67.35	79.53
Long-Term Debt	72.8	92.25	285.1	84.48	110.37	66.34
Long-Term Leases	15.18	9.1	15.35	20.84	18.53	16.9
Long-Term Unearned Revenue	4.48	4.57	4.77	2.95	1.49	-
Long-Term Deferred Tax Liabilities	-	0.05	-	0.01	-	-
Total Liabilities	295.84	298.18	529.56	205.02	197.74	162.77
Common Stock	310.28	276.01	193.67	166.34	113.46	78.06
Additional Paid-In Capital	317.5	296.21	36.88	36.85	12.31	8.1
Retained Earnings	231.57	245.56	167.55	63.7	48.85	56.58
Total Common Equity	791.73	817.78	398.09	266.89	174.62	142.73
Minority Interest	3.06	3.04	3.29	1.68	3.3	4.77
Shareholders' Equity	794.79	820.82	401.38	268.57	177.91	147.5
Total Liabilities & Equity	1,091	1,119	930.94	473.59	375.65	310.27
Total Debt	132.63	158.83	330.27	118.83	144.75	91.07
Net Cash (Debt)	174.34	223.6	-163.18	-43.79	-58.33	-9.29
Net Cash Per Share	5.68	7.64	-5.76	-1.68	-2.41	-0.39
Filing Date Shares Outstanding	30.23	30.38	27.72	27.38	23.24	22.38
Total Common Shares Outstanding	30.23	30.38	27.72	27.38	23.24	22.38
Working Capital	308.19	342.42	115.57	61.94	67.83	62.13
Book Value Per Share	26.19	26.91	14.36	9.75	7.51	6.38
Tangible Book Value	787.05	811.82	394.84	265.42	173.42	142.13
Tangible Book Value Per Share	26.04	26.72	14.25	9.70	7.46	6.35
Land	214.44	214.44	214.44	87.04	87.04	87.04
Buildings	263.93	260.13	241.98	-	6.2	6.2
Machinery	158.06	149.35	113.95	87.08	83.76	74.47
Construction In Progress	-	-	9.78	125.77	61.92	0.68
Leasehold Improvements	7.43	7.43	7.4	7.36	1.02	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.